Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
Recruiting · NCT07545811 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2026-09-03 | NCT07545811 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janux Therapeutics | 5 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Medical University of South Carolina - Hollings Cancer Center | Charleston | United States | 5 |
| Prisma Health Cancer Institute | Greenville | United States | 13 |
| SCRI at Mary Crowley | Dallas | United States | 6 |
| Scri Oncology Partners | Nashville | United States | 156 |
| UC San Diego Moores Cancer Center | La Jolla | United States | 22 |
| Washington University School of Medicine | St Louis | United States | 26 |